JRM

Journal of Radiology in Medicine is an international journal that published original research and articles in all areas of radiology. Its publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

EndNote Style
Index
Original Article
Determination of clinical, radiological and laboratory risk factors associated with the development of pulmonary embolism in patients with lower extremity deep vein thrombosis
Aims: This study aimed to determine the clinical, radiological and laboratory risk factors associated with the development of pulmonary embolism in patients with lower extremity deep vein thrombosis and to determine the role of the TyG index.
Methods: In this single-center retrospective study, electronic medical records of patients diagnosed with lower extremity deep vein thrombosis confirmed by ultrasonography were retrospectively reviewed. Among these patients, patients who underwent computed tomography pulmonary angiography imaging within the first 24 hours with suspected pulmonary embolism and developed pulmonary embolism were identified and recorded. Clinical, radiological and laboratory values of these patients were analyzed with statistical methods and the results were compared.
Results: Obesity, diabetes, immobility, thrombus location and high triglyceride-glucose index were determined as risk factors for the development of pulmonary embolism in patients diagnosed with deep vein thrombosis.
Conclusion: Our study findings indicate that diabetes and high triglyceride-glucose index are independent risk factors for pulmonary embolism in patients with deep vein thrombosis. This suggests that the incidence of pulmonary embolism in patients with deep vein thrombosis can be significantly reduced by controlling diabetes and related factors contributing to high triglyceride-glucose index.


1. Zhang J, Chen Y, Wang Z, Chen X, Liu Y, Liu M. Anatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: a 10-year retrospective analysis. Front Cardiovasc Med. 2023;10:1154875. doi:10.3389/fcvm.2023.1154875
2. Yao M, Ma J, Wu D, et al. Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy. Front Immunol. 2023;14:1198952. doi:10.3389/fimmu.2023.1198952
3. Navarrete S, Solar C, Tapia R, Pereira J, Fuentes E, Palomo I. Pathophysiology of deep vein thrombosis. Clin Exp Med. 2023;23(3):645-654. doi:10.1007/s10238-022-00829-w
4. Li Y, He Y, Meng Y, et al. Development and validation of a prediction model to estimate risk of acute pulmonary embolism in deep vein thrombosis patients. Sci Rep. 2022;12(1):649. doi:10.1038/s41598-021-04657-y
5. van Es N, Takada T, Kraaijpoel N, et al. Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis. Eur Heart J. 2023;44(32):3073-3081. doi:10.1093/eurheartj/ehad417
6. Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766
7. Zhang B, Lei H, Ambler G, et al. Association between triglyceride-glucose ındex and early neurological outcomes after thrombolysis in patients with acute ıschemic stroke. J Clin Med. 2023;12(10):3471. doi:10.3390/jcm 12103471
8. Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. doi:10.1186/s12933-022-01546-0
9. Yan Y, Zhou L, La R, et al. The association between triglyceride glucose index and arthritis: a population-based study. Lipids Health Dis. 2023;22(1):132. doi:10.1186/s12944-023-01899-9
10. Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. 2022;21(1):68. doi: 10.1186/s12933-022-01511-x
11. Tian X, Zuo Y, Chen S, et al. Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol. 2021;20(1):19. doi:10.1186/s12933-020-01210-5
12. Cui H, Liu Q, Wu Y, Cao L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):22. doi:10.1186/s12933-022-01456-1
13. Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. doi:10.1186/s12933-021-01268-9
14. Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. doi:10.1186/s12933-022-01546-0
15. Karande GY, Hedgire SS, Sanchez Y, et al Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther. 2016;6(6):493-507. doi:10.21037/cdt.2016.12.06
16. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299-304. doi:10.1089/met.2008.0034
17. Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654-672. doi:10.1038/s41580-018-0044-8
18. Zhang B, Liu L, Ruan H, et al. Triglyceride-glucose index linked to hospital mortality in critically ill stroke: an observational multicentre study on eICU database. Front Med (Lausanne). 2020;7:591036. doi:10.3389/fmed.2020. 591036
19. Zhou Y, Pan Y, Yan H, et al. Triglyceride glucose index and prognosis of patients with ischemic stroke. Front Neurol. 2020;11:456. doi:10.3389/fneur.2020.00456
20. Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021;55(2):91-96. doi:10.1080/14017431.2020.1846774
21. van Schouwenburg IM, Mahmoodi BK, Veeger NJ, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012-1018. doi:10.1111/j.1538-7836. 2012.04707.x
22. Kain K, Catto AJ, Grant PJ. Associations between insulin resistance and thrombotic risk factors in high-risk south Asian subjects. Diabet Med. 2003;20(8):651-655. doi:10.1046/j.1464-5491.2003.00958.x
23. Deng XL, Liu Z, Wang C, Li Y, Cai Z. Insulin resistance in ischemic stroke. Metab Brain Dis. 2017;32(5):1323-1334. doi:10.1007/s11011-017-0050-0
24. Lu H, Lei S, Zhao J, Chen N. Platelet activity in Chinese obese adolescents with and without insulin resistance. J Thromb Thrombolysis. 2014;37(2):165-170. doi:10.1007/s11239-013-0917-9
25. Palomo I, Alarcón M, Moore-Carrasco R, Argilés JM. Hemostasis alterations in metabolic syndrome. Int J Mol Med. 2006;18(5):969-974. doi: 10.3892/ijmm.18.5.969
26. Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol. 2007;27(12):2783-2789. doi:10.1161/ATVBAHA.107.153221
27. Singh S, Goel A. A study of modified Wells score for pulmonary embolism and age-adjusted D-dimer values in patients at risk for deep venous thrombosis. J Family Med Prim Care. 2023;12(9):2020-2023. doi:10.4103/jfmpc.jfmpc_2455_22
28. Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med. 2004;116(5):291-299. doi:10.1016/j.amjmed.2003.09.041
29. Gong B, Xu Q, Pang Y, Hu, J. Clinical features of patients with venous thromboembolism: 177 case analysis in 10 years. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(4):453-457. doi:10.3760/cma.j.issn.2095-4352. 2019.04.016
30. Leibson CL, Petterson TM, Smith CY, et al. Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments. Chest. 2014;146(2):412-421. doi:10.1378/chest.13-2652
31. Abdelmalik BH, Leslom MMA, Gameraddin M, et al. Assessment of lower limb deep vein thrombosis: characterization and associated risk factors using triplex Doppler imaging. Vasc Health Risk Manag. 2023;19:279-287. doi:10.2147/VHRM.S409253
32. Roy PM, Friou E, Germeau B, et al. Derivation and validation of a 4-level clinical pretest probability score for suspected pulmonary embolism to safely decrease imaging testing. JAMA Cardiol. 2021;6(6):669-677. doi:10. 1001/jamacardio.2021.0064
33. Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(4):812-818. doi:10.1160/TH14-10-0868
34. Fabbian F, Gallerani M, Pala M, et al. In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy. Intern Emerg Med. 2013;8(8):735-740. doi: 10.1007/s11739-012-0892-8
35. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182-1189. doi:10.1001/archinte.162.10.1182
36. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia. 2005;48(5):1017-1021. doi:10.1007/s00125-005-1715-5
37. Peng YH, Lin YS, Chen CH, et al. Type 1 diabetes is associated with an increased risk of venous thromboembolism: a retrospective population-based cohort study. PLoS One. 2020;15(1):e0226997. doi:10.1371/journal.pone.0226997
38. Schmitt VH, Hobohm L, Munzel T, Wenzel P, Gori T, Keller K. Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction. Diabetes Metab. 2021;47(4):101211. doi:10.1016/j.diabet.2020.11.003
39. Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev. 2011;27(5):436-460. doi:10.1002/dmrr.1195
40. Zhang C, Li Q, Yu H, et al. Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(5):725-733. doi:10.1016/j.jvsv.2019.11.010
41. Qiu T, Zhang T, Liu L, et al. The anatomic distribution and pulmonary embolism complications of hospital-acquired lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2021;9(6):1391-1398.e3. doi:10.1016/j.jvsv.2021.03.004
42. Konstantinides SV, Torbicki A, Agnelli G, et al. Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2015;36(39):2666. doi:10.1093/eurheartj/ehv131
Volume 2, Issue 1, 2025
Page : 6-11
_Footer